Hematology and medical oncology

Introduction of the medical department

The Department of Oncology and Hematology is an internal medicine department that diagnoses and treats various malignant tumors (cancer) and can be broadly divided into the Department of Oncology and the Department of Hematology. which is for solid tumors, surgery, radiation, or chemotherapy can be performed, and the Department of Hematology-Oncology is a department that specializes in chemotherapy.

Major Diseases

  • Hematology
    Bleeding disorders such as acute leukemia, chronic leukemia, multiple myeloma, lymphoma, polycythemia vera, essential thrombocytosis, myelodysplastic syndrome, thrombocytopenia, anemia, and hemophilia.
  • Oncology
    Esophageal cancer, stomach cancer, colon cancer, lung cancer, breast cancer, head and neck cancer, hepatobiliary cancer, pancreatic cancer, sarcoma, cervical cancer, ovarian cancer, kidney cancer, bladder cancer, prostate cancer, thyroid cancer, etc.

Major procedures

  • Anticancer treatment
    Depending on the method of administration, anticancer drugs can be broadly divided into oral drugs and injectable drugs administered intravenously. Depending on the type of anticancer drug, there are differences in the method of administration, time required for administration, and side effects. If cancer has spread to the central nervous system, such as the brain or spinal cord, intrathecal chemotherapy, which involves administering anticancer drugs into the space where the cerebrospinal fluid is located, may be performed.
  • Hematopoietic stem cell transplantation
    Previously commonly called bone marrow transplantation, this is a procedure in which hematopoietic stem cells (cells that produce blood) obtained from bone marrow or peripheral blood are injected after administering a high dose of anticancer drugs. It is mainly used to treat blood cancers such as acute leukemia or myelodysplastic syndrome. Depending on the source of hematopoietic stem cells, autologous hematopoietic stem cell transplantation (from the patient himself), foreign hematopoietic stem cell transplantation, or allogeneic hematopoietic stem cell transplantation (from an immunologically similar person) (when obtained), umbilical cord hematopoietic stem cell transplant (when obtained from placental tissue after birth of a newborn). The process of transplanting hematopoietic stem cells is generally not much different from the process of receiving a blood transfusion, and the hematopoietic stem cells are injected into the patient's body through an intravenous injection.
  • Face-to-face multidisciplinary treatment
    It is a treatment system in which specialists from the departments of pathology, radiology, surgery, and radiation oncology come together to discuss the optimal treatment policy not only for various solid cancers but also for blood cancers. We are improving cancer cure rates and treatment outcomes by providing personalized treatment to patients by listening to the opinions of multiple specialists and establishing an integrated treatment plan during a single visit. Patients and their families can participate in treatment together to determine treatment methods, as well as consult with each specialist.
  • Hematopoietic stem cell transplantation
    It is a treatment system in which specialists from the departments of pathology, radiology, surgery, and radiation oncology come together to discuss the optimal treatment policy not only for various solid cancers but also for blood cancers. We are improving cancer cure rates and treatment outcomes by providing personalized treatment to patients by listening to the opinions of multiple specialists and establishing an integrated treatment plan during a single visit. Patients and their families can participate in treatment together to determine treatment methods, as well as consult with each specialist.
  • Hematopoietic stem cell transplantation

Major Investigations

Bone marrow examination: Performed to diagnose diseases that primarily occur in the bone marrow, such as leukemia, multiple myeloma, and aplastic anemia, to evaluate response to treatment during treatment, and to check whether solid tumors have invaded the bone marrow. This is the inspection method.
Time required: approximately 30 minutes
Location: Bone marrow transplant center on the 2nd floor of the new building
Various imaging tests such as CT, PET-CT, etc.